Finance

Lists
6CQ:FRA
Cresco Labs Inc
€0,64
-3,20%
(-0,021) 1D
4 Sep., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 6CQ...
Open
€0,62
High
€0,64
Low
€0,62
Mkt. cap
381,13 m
Avg. vol.
626,00
Volume
0,00
52-wk high
€1,90
52-wk low
€0,53
No. of employees
3 k
Open
€0,62
High
€0,64
Low
€0,62
Mkt. cap
381,13 m
Avg. vol.
626,00
Volume
0,00
52-wk high
€1,90
52-wk low
€0,53
No. of employees
3 k
Profile
Cresco Labs, Inc. is a publicly traded, vertically integrated cannabis and medical marijuana company based in Chicago, Illinois, with current retail operations in nine states where marijuana has been legalized for medical use. The company's stock trades on the Canadian Securities Exchange under the ticker symbol CL, and in over-the-counter markets in the United States with the ticker symbol CRLBF. Wikipedia
About Cresco Labs Inc
CEO-
Employees2,9 k
Founded2013
HeadquartersChicago, Illinois, Verenigde State van Amerika
SectorPharmaceutical industry
Websitecrescolabs.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
164,91 m
161,55 m
151,32 m
173,34 m
Cost of goods sold
85,55 m
78,23 m
75,88 m
86,39 m
Cost of revenue
85,55 m
78,23 m
75,88 m
86,39 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
53,53 m
60,43 m
59,36 m
66,63 m
Operating expense
59,17 m
65,40 m
64,28 m
73,59 m
Total operating expenses
144,72 m
143,63 m
140,15 m
159,98 m
Operating income
20,19 m
17,92 m
11,17 m
13,36 m
Other non operating income
4,21 m
4,23 m
1,34 m
-233,00 k
EBT including unusual items
-10,10 m
-87,15 m
-2,79 m
-3,60 m
EBT excluding unusual items
10,06 m
7,62 m
-2,75 m
-1,76 m
Income tax expense
11,87 m
1,80 m
14,22 m
-18,97 m
Effective tax rate
-117,48%
-2,07%
-508,95%
527,42%
Other operating expenses
-
-
-
-
Net income
-17,05 m
-87,59 m
-13,07 m
16,80 m
Net profit margin
-10,34%
-54,22%
-8,64%
9,69%
Earnings per share
0,01
-0,03
-0,04
0,06
Interest and investment income
699,00 k
1,30 m
407,00 k
407,00 k
Interest expense
-15,27 m
-15,63 m
-15,33 m
-15,51 m
Net interest expenses
-14,57 m
-14,33 m
-14,93 m
-15,10 m
Depreciation and amortization charges
5,64 m
4,97 m
4,92 m
6,96 m
EBITDA
33,05 m
28,68 m
23,39 m
26,02 m
Gain or loss from assets sale
-2,60 m
352,00 k
-
1,93 m
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme